Back
ESC2025 Premium Access

Impact of TAVR on GDMT in patients with severe aortic stenosis and HFrEF

Session: Treating heart failure
Topic: Pharmacotherapy
Speaker: Doctor J. Galo (Washington, DC, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jason Galo

Georgetown University, Washington, DC (United States of America)
0 follower

5 more presentations in this session

Ivabradine improves win ratios of outcomes in HFrEF patients

Speaker: Associate Professor A. Abdin (Homburg, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Association of atrial fibrillation with heart failure measurements of the HeartLogic multi-sensor remote monitoring algorithm: data from the DANLOGIC-HF trial

Speaker: Doctor F. Fussing (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Safety and long-term outcomes of heart failure drug minimization in patients with improved ejection fraction: SLIM-HF study

Speaker: Doctor Y. Luo (Rotterdam, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Perception versus perception decoded using a pan indian survey on the awareness and utilization of GDMT in heart failure in India

Speaker: Doctor P. Jayagopal (Palakkad, IN)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of cannabis use on mortality among patients with heart failure with reduced ejection fraction

Speaker: Assistant Professor I. Kamel (Boston, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Treating heart failure

Speakers: Doctor J. Galo, Associate Professor A. Abdin, Doctor F. Fussing, Doctor Y. Luo, Doctor P. Jayagopal...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources